BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 22324292)

  • 1. Glycated Hemoglobin A(1c) as screening for diabetes mellitus in HIV-infected individuals.
    Eckhardt BJ; Holzman RS; Kwan CK; Baghdadi J; Aberg JA
    AIDS Patient Care STDS; 2012 Apr; 26(4):197-201. PubMed ID: 22324292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of glycated hemoglobin in screening and diagnosing type 2 diabetes mellitus in Chinese subjects.
    Yu Y; Ouyang XJ; Lou QL; Gu LB; Mo YZ; Ko GT; Chow CC; So WY; Ma R; Kong A; Brown N; Nan J; Chan J; Bian RW
    Korean J Intern Med; 2012 Mar; 27(1):41-6. PubMed ID: 22403498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycated hemoglobin in diagnosis of diabetes mellitus and pre-diabetes; validation by oral glucose tolerance test. The Tromsø OGTT Study.
    Hutchinson MS; Joakimsen RM; Njølstad I; Schirmer H; Figenschau Y; Jorde R
    J Endocrinol Invest; 2012 Oct; 35(9):835-40. PubMed ID: 22186659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening.
    Schöttker B; Raum E; Rothenbacher D; Müller H; Brenner H
    Eur J Epidemiol; 2011 Oct; 26(10):779-87. PubMed ID: 21947790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective analysis of the fasting plasma glucose and glycosylated hemoglobin and pharmacotherapy change patterns among type 2 diabetes mellitus patients.
    Davidson J; Koro C; Arondekar B; Lee BH; Fedder D
    Clin Ther; 2008 Feb; 30(2):287-93. PubMed ID: 18343267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of HbA1c for incident diabetes among subjects with impaired glucose tolerance--analysis of the Indian Diabetes Prevention Programmes.
    Ramachandran A; Snehalatha C; Samith Shetty A; Nanditha A
    Diabet Med; 2012 Jan; 29(1):94-8. PubMed ID: 21790773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HbA(1c) measurement for the diagnosis of diabetes: is it enough?
    Cavagnolli G; Comerlato J; Comerlato C; Renz PB; Gross JL; Camargo JL
    Diabet Med; 2011 Jan; 28(1):31-5. PubMed ID: 21210540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing incident diabetes as defined by fasting plasma glucose or by HbA(1c). The AusDiab, Inter99 and DESIR studies.
    Soulimane S; Simon D; Shaw JE; Zimmet PZ; Vol S; Vistisen D; Magliano DJ; Borch-Johnsen K; Balkau B
    Diabet Med; 2011 Nov; 28(11):1311-8. PubMed ID: 21824186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fasting plasma glucose and hemoglobin A1c in identifying and predicting diabetes: the strong heart study.
    Wang W; Lee ET; Howard BV; Fabsitz RR; Devereux RB; Welty TK
    Diabetes Care; 2011 Feb; 34(2):363-8. PubMed ID: 21270194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemoglobin A1c as a screen for previously undiagnosed prediabetes and diabetes in an acute-care setting.
    Silverman RA; Thakker U; Ellman T; Wong I; Smith K; Ito K; Graff K
    Diabetes Care; 2011 Sep; 34(9):1908-12. PubMed ID: 21775751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of HbA(1C) testing to diagnose pre-diabetes in high risk African American children: a comparison with fasting glucose and HOMA-IR.
    Sharma S; Fleming SE
    Diabetes Metab Syndr; 2012; 6(3):157-62. PubMed ID: 23158980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of HbA1c combined FPG on screening diabetes in health check-up.
    Li LJ; Zhou JX; Chen HT; Song YL; Xue YM
    Asian Pac J Trop Med; 2012 Jun; 5(6):472-5. PubMed ID: 22575981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HbA(1c) as a diagnostic tool for diabetes and pre-diabetes: the Bangladesh experience.
    Bhowmik B; Diep LM; Munir SB; Rahman M; Wright E; Mahmood S; Afsana F; Ahmed T; Khan AK; Hussain A
    Diabet Med; 2013 Mar; 30(3):e70-7. PubMed ID: 23199158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: effect of anemia and erythropoietin injection.
    Inaba M; Okuno S; Kumeda Y; Yamada S; Imanishi Y; Tabata T; Okamura M; Okada S; Yamakawa T; Ishimura E; Nishizawa Y;
    J Am Soc Nephrol; 2007 Mar; 18(3):896-903. PubMed ID: 17267743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HbA(1c) in adults without known diabetes from southern Europe. Impact of the new diagnostic criteria in clinical practice.
    Bernal-Lopez MR; Santamaría-Fernandez S; Lopez-Carmona D; Tinahones FJ; Mancera-Romero J; Peña-Jimenez D; Jansen-Chaparro S; Baca-Osorio AJ; Cuesta-Muñoz AL; Serrano-Rios M; Gomez-Huelgas R
    Diabet Med; 2011 Nov; 28(11):1319-22. PubMed ID: 21966956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemoglobin A1c cut-off point to identify a high risk group of future diabetes: results from the Omiya MA Cohort Study.
    Kato M; Noda M; Suga H; Nakamura T; Matsumoto M; Kanazawa Y;
    Diabet Med; 2012 Jul; 29(7):905-10. PubMed ID: 22248349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing risk profiles of individuals diagnosed with diabetes by OGTT and HbA1c The Danish Inter99 study.
    Borg R; Vistisen D; Witte DR; Borch-Johnsen K
    Diabet Med; 2010 Aug; 27(8):906-10. PubMed ID: 20653748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for pre-diabetes to predict future diabetes using various cut-off points for HbA(1c) and impaired fasting glucose: the Toranomon Hospital Health Management Center Study 4 (TOPICS 4).
    Heianza Y; Arase Y; Fujihara K; Tsuji H; Saito K; Hsieh SD; Kodama S; Shimano H; Yamada N; Hara S; Sone H
    Diabet Med; 2012 Sep; 29(9):e279-85. PubMed ID: 22510023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using HbA(1c) to improve efficacy of the american diabetes association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians: the strong heart study.
    Wang W; Lee ET; Fabsitz R; Welty TK; Howard BV
    Diabetes Care; 2002 Aug; 25(8):1365-70. PubMed ID: 12145236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.